TOP STORIES

• REGULATORY 14 Firms Flock to Get Approval for E Keppra Generics towards December Listing
  August 17, 2021

• ACADEMIA Evrysdi Debut Expands SMA Treatment Options, Improved Use Expected for All 3 Drugs: Professor
  August 16, 2021

• BUSINESS Probe Panel Urges Ono to Establish Foundation to Handle Scholarship Donations after Bribery Case
  August 16, 2021

• BUSINESS Evrysdi, Aimovig Now Available; Veklury’s Normal Distribution to Start around October
  August 13, 2021

• BUSINESS Morimoto Pharma Aims at Commercial Production of Freeze-Dried Vaccine in FY2022
  August 12, 2021

• BUSINESS Orizuru Therapeutics Boots Up to Take Over iPSC Assets from T-CiRA, Eyes IPO in 2026
  August 11, 2021

• BUSINESS HIF-PH Drugs’ Sluggish Q1 Sales Signal Tepid Uptake as Side Effect Concerns Weigh
  August 10, 2021

• BUSINESS Foreign Drug Makers Scrapping Sales Offices as Sanofi Follows GSK, Novartis, AZ
  August 6, 2021

• REGULATORY Chuikyo Calls for Balanced Price-Setting for “Specific-Use” Drugs, Sakigake Products
  August 5, 2021

• REGULATORY Ofev Faces 10%-Plus Cut in Quarterly Price Review; Veklury Gets Listing but No Copay for Now
  August 5, 2021

• REGULATORY August Listing OK’ed for Evrysdi, Veklury, Verquvo, 2 CGRP Migraine Meds and More
  August 4, 2021

• REGULATORY Veklury to Join NHI Price List to Enter Normal Distribution Channel; Peak Sales Put at 18 Billion Yen
  August 3, 2021

• REGULATORY Lilly’s Selpercatinib Clears Key Panel, in Line for September Approval
  August 2, 2021

• BUSINESS Takeda’s Q1 Sales Rise on Diabetes Divestiture; Plant Re-Inspection Results Expected Late October
  August 2, 2021

• REGULATORY AstraZeneca Vaccine OK’ed for Age 40 and Up under Emergency Program
  August 2, 2021

• ORGANIZATION New Industry Czar Vows to Balance Interests of Innovative Pharma, Gx Businesses as Budget Debate Creates Divide
  July 30, 2021

• BUSINESS Pfizer Japan Recalling Some Champix Products after Detecting Carcinogen
  July 29, 2021

• ACADEMIA Osteoporosis Society Greatly Alarmed by Vitamin D3 Analog Shortages, Might Take Further Measures
  July 29, 2021

• REGULATORY Forxiga Clears PAFSC, in Line to Become Japan’s 1st CKD Drug in August
  July 29, 2021

• BUSINESS Keytruda Keeps Top Drug Crown in FY2020 despite Double-Digit Dip: Tally
  July 28, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 94
• 95
• 96
• 97
• 98
• 99
• 100
• 101
• 102
• …
• Next ›
• 最終 »